Starting Thursday, all nine of Fine Fettle’s cannabis dispensaries in Connecticut will be hybrid facilities, serving both medical patients and adult-use customers.
The conversions follow recent changes to state cannabis regulations that allow recreational retailers to operate as hybrid dispensaries serving registered medical marijuana patients.
The expansion comes as Connecticut’s total cannabis sales declined 1.2% to $290 million in 2025 from $293.6 million in 2024, even as the number of products sold increased 11.8% to 8.69 million units, according to state data.
Medical marijuana sales fell 22.6% in 2025 to $72.5 million from $93.6 million in 2024, while adult-use sales grew 8.8% to $217.5 million.
Medical marijuana now represents 25% of Connecticut’s total cannabis market, down from 32% in 2024, state data shows.
Medical marijuana patients must obtain physician certification and register with the state, but typically pay lower taxes than adult-use customers. Medical patients also have access to pharmacist consultations and can purchase larger quantities than recreational customers.
Fine Fettle’s locations in Manchester, Norwalk, Old Saybrook, Waterbury and West Hartford currently serve only adult-use customers and will add medical marijuana services. The company’s other four Connecticut locations are already hybrid dispensaries.
Benjamin Zachs, chief operating officer of Fine Fettle, said the conversion addresses limited medical access in some regions where the company operates.
“Patients shouldn’t have to travel far for care or be stuck with limited options,” Zachs said. “With this model, we can responsibly serve both patients and customers while keeping Connecticut’s medical community strong.”
Fine Fettle operates cannabis dispensaries in Connecticut, Massachusetts and Georgia.
